BriefIQ Markets · 8-K
Amneal stockholders approve acquisition of Kashiv BioSciences and related stock issuance at July 31, 2026 special meeting
Key Facts
- Amneal held a special meeting of stockholders on July 31, 2026.
- Proposal 2 approving issuance of 28,942,108 Common Stock shares to the Sellers was approved for Nasdaq Listing Rule 5635(a)(2) compliance.
- Each submitted proposal required approval by a majority of votes cast at the Special Meeting.
- The transaction closing remains conditional on the remaining Purchase Agreement closing conditions and is expected in the second half of 2026.
Source
Filing details
- Form
- 8-K
- Symbol
- AMRX
- Company
- Amneal Pharmaceuticals, Inc.
- CIK
- 0001723128
- Accession number
- 0001140361-26-030491
- SEC filing date
- 2026-07-31
- SEC acceptance time
- 2026-07-31T20:08:50+00:00
- RSS publication time
- 2026-07-31T20:08:50+00:00
- BriefIQ published
- 2026-07-31T20:17:10.771332+00:00
- Reporting period
- 2026-07-31